BioAtla
Stock Forecast, Prediction & Price Target
BioAtla Financial Estimates
BioAtla Revenue Estimates
BioAtla EBITDA Estimates
BioAtla Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $250K N/A | $0 -100% | $0 0% | Avg: $2.86M Low: $2.86M High: $2.86M avg. 0% | Avg: $6.56M Low: $6.56M High: $6.56M avg. 129.16% | Avg: $12.34M Low: $12.34M High: $12.34M avg. 87.95% | Avg: $83.09M Low: $83.09M High: $83.09M avg. 573.20% |
Net Income
% change YoY
| $-95.40M N/A | $-105.28M -10.35% | $-123.46M -17.26% | Avg: $-113.22M Low: $-83.13M High: $-49.01M avg. 8.29% | Avg: $-137.72M Low: $-87.91M High: $-66.41M avg. -21.64% | Avg: $-72.94M Low: $-72.94M High: $-72.94M avg. 47.03% | Avg: $-49.36M Low: $-49.36M High: $-49.36M avg. 32.31% |
EBITDA
% change YoY
| $-94.75M N/A | $-106.48M -12.37% | $-122.24M -14.79% | Avg: $-573.09K Low: $-573.09K High: $-573.09K avg. 99.53% | Avg: $-1.31M Low: $-1.31M High: $-1.31M avg. -129.16% | Avg: $-2.46M Low: $-2.46M High: $-2.46M avg. -87.95% | Avg: $-16.61M Low: $-16.61M High: $-16.61M avg. -573.20% |
EPS
% change YoY
| -$2.76 N/A | -$2.7 2.17% | -$2.58 4.44% | Avg: -$1.48 Low: -$1.74 High: -$1.03 avg. 42.67% | Avg: -$1.62 Low: -$1.84 High: -$1.39 avg. -9.53% | Avg: -$1.53 Low: -$1.53 High: -$1.53 avg. 5.76% | Avg: -$1.03 Low: -$1.03 High: -$1.03 avg. 32.31% |
Operating Expenses
% change YoY
| $96.69M N/A | $108.14M 11.84% | $129.68M 19.92% | Avg: $104.19M Low: $104.19M High: $104.19M avg. -19.65% | Avg: $238.78M Low: $238.78M High: $238.78M avg. 129.16% | Avg: $448.81M Low: $448.81M High: $448.81M avg. 87.95% | Avg: $3.02B Low: $3.02B High: $3.02B avg. 573.20% |
FAQ
What is BioAtla stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 16.50% in 2025-2028.
We have gathered data from 3 analysts. Their low estimate is -83.13M, average is -113.22M and high is -49.01M.
What is BioAtla stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 197.58% in 2025-2028.
We have gathered data from 2 analysts. Their low revenue estimate is $2.86M, average is $2.86M and high is $2.86M.
What is BioAtla stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 17.80% in 2025-2028.
We have gathered data from 3 analysts. Their low earnings per share estimate is -$1.74, average is -$1.48 and high is $-1.02.
What is the best performing analyst?
In the last twelve months analysts have been covering BioAtla stock. The most successful analyst is Reni Benjamin.